A shocking new study reveals that a condition that can lead to limb amputation is far more prevalent and deadly than ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...
The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...
CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
For patients with symptomatic peripheral artery disease and type 2 diabetes, semaglutide use is associated with increased ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...
Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...